Alto Neuroscience, Inc. (ANRO)

NYSE HEALTHCARE
$22.74 +4.36% RSI 57 Neutral Add Alert

Moving Averages

SMA 200
$15.90
Price above

Company Profile

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company that engages in the psychiatry drug development business. The company is headquartered in Los Altos, California.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$752.06M
P/E Ratio
None
EPS
$-2.43
Beta
1.253
Dividend Yield
0.00%
52-Week High
$28.44
52-Week Low
$2.15

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 48.0
VRTX
Vertex Pharmaceuticals Inc
RSI 64.0
CRSP
CRISPR Therapeutics AG
RSI 56.0
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 49.0
MRNA
Moderna Inc
RSI 64.0
VKTX
Viking Therapeutics Inc
RSI 60.0
SRPT
Sarepta Therapeutics Inc
RSI 54.0
EDIT
Editas Medicine Inc
RSI 48.0
IOVA
Iovance Biotherapeutics Inc
RSI 54.0
NVAX
Novavax Inc
RSI 48.0

Data last updated: June 13, 2026 at 9:49 AM EDT

Track ANRO for free

Get e-mail RSI alerts when Alto Neuroscience, Inc. enters oversold or overbought territory. Free forever.

Add Alert